These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 28366425)
1. Osteoporosis in the Women's Health Initiative: Another Treatment Gap? Sattari M; Cauley JA; Garvan C; Johnson KC; LaMonte MJ; Li W; Limacher M; Manini T; Sarto GE; Sullivan SD; Wactawski-Wende J; Beyth RJ Am J Med; 2017 Aug; 130(8):937-948. PubMed ID: 28366425 [TBL] [Abstract][Full Text] [Related]
2. Insights into the epidemiology of postmenopausal osteoporosis: the Women's Health Initiative. Jackson RD; Mysiw WJ Semin Reprod Med; 2014 Nov; 32(6):454-62. PubMed ID: 25321423 [TBL] [Abstract][Full Text] [Related]
3. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries. Yusuf AA; Matlon TJ; Grauer A; Barron R; Chandler D; Peng Y Arch Osteoporos; 2016 Dec; 11(1):31. PubMed ID: 27696099 [TBL] [Abstract][Full Text] [Related]
4. Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk. Degli Esposti L; Girardi A; Saragoni S; Sella S; Andretta M; Rossini M; Giannini S; Endocrine; 2019 May; 64(2):367-377. PubMed ID: 30515678 [TBL] [Abstract][Full Text] [Related]
5. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures. Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521 [TBL] [Abstract][Full Text] [Related]
6. The clinician's guide to prevention and treatment of osteoporosis. LeBoff MS; Greenspan SL; Insogna KL; Lewiecki EM; Saag KG; Singer AJ; Siris ES Osteoporos Int; 2022 Oct; 33(10):2049-2102. PubMed ID: 35478046 [TBL] [Abstract][Full Text] [Related]
7. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment. Modi A; Tang J; Sen S; Díez-Pérez A Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648 [TBL] [Abstract][Full Text] [Related]
8. Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population. Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O J Manag Care Spec Pharm; 2017 Nov; 23(11):1178-1190. PubMed ID: 29083977 [TBL] [Abstract][Full Text] [Related]
9. Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors. Castro-Lionard K; Dargent-Molina P; Fermanian C; Gonthier R; Cassou B Drugs Aging; 2013 Dec; 30(12):1029-38. PubMed ID: 24114665 [TBL] [Abstract][Full Text] [Related]
10. Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population. Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O Osteoporos Int; 2017 Aug; 28(8):2485-2494. PubMed ID: 28536737 [TBL] [Abstract][Full Text] [Related]
11. Bone health in women with premature ovarian insufficiency/early menopause: a 23-year longitudinal analysis. Jones AR; Enticott J; Ebeling PR; Mishra GD; Teede HT; Vincent AJ Hum Reprod; 2024 May; 39(5):1013-1022. PubMed ID: 38396142 [TBL] [Abstract][Full Text] [Related]
12. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009. Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929 [TBL] [Abstract][Full Text] [Related]
13. Disparities in osteoporosis treatments. Liu Z; Weaver J; de Papp A; Li Z; Martin J; Allen K; Hui S; Imel EA Osteoporos Int; 2016 Feb; 27(2):509-19. PubMed ID: 26216226 [TBL] [Abstract][Full Text] [Related]
14. Evaluation and Treatment of Osteoporosis. O'Connor KM Med Clin North Am; 2016 Jul; 100(4):807-26. PubMed ID: 27235616 [TBL] [Abstract][Full Text] [Related]
15. Fracture prevention service to bridge the osteoporosis care gap. Ruggiero C; Zampi E; Rinonapoli G; Baroni M; Serra R; Zengarini E; Baglioni G; Duranti G; Ercolani S; Conti F; Caraffa A; Mecocci P; Brandi ML Clin Interv Aging; 2015; 10():1035-42. PubMed ID: 26150707 [TBL] [Abstract][Full Text] [Related]
16. Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy. Wade SW; Satram-Hoang S; Nadkar A; Macarios D; Tosteson AN Clin Ther; 2011 Dec; 33(12):2006-15. PubMed ID: 22099387 [TBL] [Abstract][Full Text] [Related]
17. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis. Nurmi-Lüthje I; Lüthje P; Kaukonen JP; Kataja M; Kuurne S; Naboulsi H; Karjalainen K Drugs Aging; 2009; 26(5):409-21. PubMed ID: 19552493 [TBL] [Abstract][Full Text] [Related]
18. Orthopedic-Metabolic Collaborative Management for Osteoporotic Hip Fracture. Rotman-Pikielny P; Frankel M; Lebanon OT; Yaacobi E; Tamar M; Netzer D; Nabriski D; Nyska M; Brin YS Endocr Pract; 2018 Aug; 24(8):718-725. PubMed ID: 30084682 [TBL] [Abstract][Full Text] [Related]
19. Long-term effect of the Women's Health Initiative study on antiosteoporosis medication prescribing. Lee E; Maneno MK; Wutoh AK; Zuckerman IH J Womens Health (Larchmt); 2010 May; 19(5):847-54. PubMed ID: 20459329 [TBL] [Abstract][Full Text] [Related]
20. Age of menopause and fracture risk in postmenopausal women randomized to calcium + vitamin D, hormone therapy, or the combination: results from the Women's Health Initiative Clinical Trials. Sullivan SD; Lehman A; Nathan NK; Thomson CA; Howard BV Menopause; 2017 Apr; 24(4):371-378. PubMed ID: 27801706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]